Concepedia

Author

S A Holden

Dana-Farber Cancer Institute

Also Known As

Holden, Sylvia A., S A Holden, Sylvia A. Holden

7

Publications

256

Citations

7

H-Index

32

Concepts

All Affiliations

Dana-Farber Cancer Institute
SA

About

S A Holden is an author at Dana-Farber Cancer Institute specializing in pharmacology, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

256

2

Cell Biology

4

4

151

3

Natural Sciences

3

3

148

4

Biochemistry

2

2

88

5

Health Sciences

1

1

40

S A Holden

×

7

Publications

256

Citations

7

H-Index

YearCitations

Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.

Beverly A. Teicher, S A Holden, C A Cucchi,

PubMed

1988

60

Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide.

Beverly A. Teicher, David J. Waxman, S A Holden,

PubMed

1989

46

Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.

B A Teicher, Terence S. Herman, S A Holden,

PubMed

1991

42

Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.

J P Eder, Beverly A. Teicher, S A Holden,

PubMed

1989

40

Effect of Oxygen on the Cytotoxicity and Antitumor Activity of Etoposide<xref ref-type="fn" rid="FN2">2</xref>

B A Teicher, S A Holden, Christopher M. Rose

JNCI Journal of the National Cancer Institute

1985

35

Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.

Beverly A. Teicher, T S Herman, Juichi Tanaka,

PubMed

1991

19

Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA®/carbogen/radiation

S A Holden, Terence S. Herman, Beverly A. Teicher

Radiotherapy and Oncology

1990

14

Page 1